Fage D, Scatton B
Eur J Pharmacol. 1986 Oct 7;129(3):359-62. doi: 10.1016/0014-2999(86)90447-4.
In contrast to D-2 or mixed D-1/D-2 receptor antagonists which decrease rat striatal acetylcholine levels, the D-1 receptor antagonist SCH 23390 increased this biochemical parameter (ED50 = 0.04 mg/kg s.c.) suggesting a reduction of acetylcholine turnover. SCH 23390 blocked the ability of haloperidol or sulpiride to diminish striatal acetylcholine levels and potentiated the increase in this biochemical parameter induced by the selective D-2 receptor agonist LY 141865. These findings indicate that blockade of D-1 and D-2 receptors causes opposite actions on striatal cholinergic neurons.
与降低大鼠纹状体乙酰胆碱水平的D - 2或混合D - 1/D - 2受体拮抗剂不同,D - 1受体拮抗剂SCH 23390提高了这一生化指标(皮下注射半数有效剂量=0.04mg/kg),提示乙酰胆碱周转率降低。SCH 23390阻断了氟哌啶醇或舒必利降低纹状体乙酰胆碱水平的能力,并增强了选择性D - 2受体激动剂LY 141865诱导的这一生化指标的升高。这些发现表明,阻断D - 1和D - 2受体对纹状体胆碱能神经元产生相反的作用。